Summit Therapeutics Inc.
SMMTNASDAQHealthcare● Active
$14.11
$-0.66(-4.47%)
Market Cap$10.9B
P/E Ratio—
52W High$30.98
52W Low$13.81
Summit Therapeutics Inc.（SMMT）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · SMMT · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.53B | $0.33B | $0.15B | $0.28B | $0.05B |
| Net Receivables | $0.00B | $0.00B | $0.00B | $0.00B | $0.01B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.53B | $0.34B | $0.15B | $0.54B | $0.07B |
| PP&E Net | $0.02B | $0.01B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.01B |
| Total Assets | $0.56B | $0.35B | $0.16B | $0.54B | $0.08B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.02B | $0.00B |
| Accounts Payable | $0.02B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Liabilities | $0.05B | $0.03B | $0.02B | $0.03B | $0.02B |
| Long-Term Debt | $0.00B | $0.00B | $0.08B | $0.40B | $0.00B |
| Total Liabilities | $0.07B | $0.04B | $0.10B | $0.44B | $0.02B |
| Stockholders Equity | |||||
| Retained Earnings | ($1.70B) | ($0.97B) | ($0.79B) | ($0.31B) | ($0.22B) |
| Total Stockholders Equity | $0.49B | $0.31B | $0.06B | $0.10B | $0.06B |
| Total Liab & Equity(computed) | $0.56B | $0.35B | $0.16B | $0.54B | $0.08B |
| Debt Summary | |||||
| Total Debt | $0.02B | $0.01B | $0.08B | $0.42B | $0.00B |
| Net Debt | ($0.15B) | ($0.08B) | $0.03B | $0.14B | ($0.05B) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Summit Therapeutics Inc.
关于Summit Therapeutics Inc.（SMMT）资产负债表
Summit Therapeutics Inc.总资产$0.56B，现金及短期投资$0.53B，总负债$0.07B，总债务$0.02B，股东权益$0.49B。
常见问题
SMMT · 4 问Summit Therapeutics Inc.总债务$0.02B，净债务($0.15B)。
SMMT total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10